Gene · 155
Papers3,802
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,321 to 1,340 of 3,802
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic efficacy of mirabegron 25 mg monotherapy in patients with nocturia-predominant hypersensitive bladder. | Tzu Chi Med J | 2020 | 32110517 | PubTator, text mining | PubMed |
| Precision medicine in the diagnosis and treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia. | Tzu Chi Med J | 2020 | 32110513 | PubTator, text mining | PubMed |
| p-Synephrine, ephedrine, p-octopamine and m-synephrine: Comparative mechanistic, physiological and pharmacological properties. | Phytother Res | 2020 | 32101364 | PubTator, text mining | PubMed |
| Genetic Background of Hypertension in Connective Tissue Diseases. | J Immunol Res | 2020 | 32090130 | PubTator, text mining | PubMed |
| α2-Adrenergic Receptor in Liver Fibrosis: Implications for the Adrenoblocker Mesedin. | Cells | 2020 | 32085378 | PubTator, text mining | PubMed |
| Network and pathway-based analyses of genes associated with osteoporosis. | Medicine (Baltimore) | 2020 | 32080087 | PubTator, text mining | PubMed |
| Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats. | Antioxidants (Basel) | 2020 | 32079097 | PubTator, text mining | PubMed |
| Incendiary Leptin. | Nutrients | 2020 | 32069871 | PubTator, text mining | PubMed |
| International Phase III, Randomized, Double-Blind, Placebo and Active Controlled Study to Evaluate the Safety and Efficacy of Vibegron in Patients with Symptoms of Overactive Bladder: EMPOWUR. | J Urol | 2020 | 32068484 | PubTator, text mining | PubMed |
| Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis. | Investig Clin Urol | 2020 | 32055752 | PubTator, text mining | PubMed |
| Ginsenoside Rg3 Induces Browning of 3T3-L1 Adipocytes by Activating AMPK Signaling. | Nutrients | 2020 | 32046061 | PubTator, text mining | PubMed |
| Human cytomegalovirus promoting endothelial cell proliferation by targeting regulator of G-protein signaling 5 hypermethylation and downregulation. | Sci Rep | 2020 | 32041970 | PubTator, text mining | PubMed |
| Combination drug therapy against OAB normalizes micturition parameters and increases the release of nitric oxide during chemically induced cystitis. | Pharmacol Res Perspect | 2020 | 32030913 | PubTator, text mining | PubMed |
| Modern pharmacological treatment of obese patients. | Ther Adv Endocrinol Metab | 2020 | 32030121 | PubTator, text mining | PubMed |
| The ADRB3 rs4994 polymorphism increases risk of childhood and adolescent overweight/obesity for East Asia's population: an evidence-based meta-analysis. | Adipocyte | 2020 | 32008426 | PubTator, text mining | PubMed |
| Hydrocarboxylic acid receptor 1 in BAT regulates glucose uptake in mice fed a high-fat diet. | PLoS One | 2020 | 31999787 | PubTator, text mining | PubMed |
Efficacy of vibegron, a novel β3-adrenoreceptor agonist, on severe urgency urinary incontinence related to overactive bladder: post hoc analysis of a randomized, placebo-controlled, double-blind, comparative phase 3 study. | BJU Int | 2020 | 31991511 | PubTator, text mining | PubMed |
| Role of small proliferative adipocytes: possible beige cell progenitors. | J Endocrinol | 2020 | 31990671 | PubTator, text mining | PubMed |
| Adrenal cortex hypoxia modulates aldosterone production in heart failure. | Biochem Biophys Res Commun | 2020 | 31982132 | PubTator, text mining | PubMed |
| Therapeutic Efficacy of onabotulinumtoxinA Delivered Using Various Approaches in Sensory Bladder Disorder. | Toxins (Basel) | 2020 | 31979383 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/155/papers?page=67